V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20197039 | 20125372 | 1.65 | 46.6 | Palliative (P) | 2017-01-06 | 2017-01-09 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100816246 |
| 20197046 | 20125373 | 1.59 | 71.6 | Palliative (P) | 2016-11-24 | 2018-07-07 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100188428 |
| 20197051 | 20125374 | 1.58 | 93.2 | Neo-adjuvant (N) | 2016-07-15 | 2016-11-05 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100566150 |
| 20197052 | 20125375 | 1.8 | 77.1 | Palliative (P) | 2017-03-15 | 2017-03-23 | Trastuzumab | 02 | N | TRASTUZUMAB | 100331086 |
| 20197053 | 20125376 | 1.61 | 98.6 | Palliative (P) | 2019-03-23 | 2019-04-04 | CETUXIMAB | 02 | Y | CETUXIMAB | 101167388 |
| 20197058 | 20125377 | 1.58 | 69.2 | Palliative (P) | 2018-02-27 | 2018-03-07 | Trastuzumab | 02 | N | TRASTUZUMAB | 100291601 |
| 20197066 | 20125378 | 1.62 | 80 | Palliative (P) | 2017-12-27 | 2018-01-04 | Trastuzumab | 02 | N | TRASTUZUMAB | 100822350 |
| 20197076 | 20125379 | 1.66 | 75 | Palliative (P) | 2018-02-09 | 2018-02-21 | CETUXIMAB | 02 | N | CETUXIMAB | 100667551 |
| 20197077 | 20125380 | 1.49 | 117 | Adjuvant (A) | 2019-05-24 | 2019-06-05 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100931842 |
| 20197078 | 20125381 | 1.52 | 70 | null | 2018-10-11 | 2018-10-18 | Trastuzumab | 02 | N | TRASTUZUMAB | 101178434 |
| 20197085 | 20125382 | 1.77 | 77.7 | Palliative (P) | 2015-04-07 | 2016-04-21 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100110659 |
| 20197094 | 20125383 | 1.83 | 78 | Curative (C) | 2018-09-12 | 2018-11-06 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100266797 |
| 20197095 | 20125384 | 1.82 | 69 | Neo-adjuvant (N) | 2019-12-17 | 2019-12-22 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100181218 |
| 20197096 | 20125385 | 1.74 | 73.4 | null | 2019-05-20 | 2019-05-24 | CETUXIMAB | N | N | CETUXIMAB | 101657155 |
| 20197098 | 20125386 | 1.55 | 82.6 | Curative (C) | 2018-06-10 | 2018-07-01 | Trastuzumab | 02 | N | TRASTUZUMAB | 100925958 |
| 20197106 | 20125387 | 1.64 | 128.8 | Palliative (P) | 2017-12-22 | 2018-01-18 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100902132 |
| 20197108 | 20125388 | 1.81 | 76 | null | 2019-06-30 | 2020-01-07 | Cetuximab 14 day | 02 | null | CAPECITABINE + CISPLATIN | 100266923 |
| 20197111 | 20125389 | 1.59 | 90.3 | Curative (C) | 2016-11-21 | 2016-11-28 | Cetuximab 14 day | N | N | TRASTUZUMAB | 101200549 |
| 20197114 | 20125390 | 1.72 | 108.4 | Neo-adjuvant (N) | 2018-09-19 | 2018-09-22 | Trastuzumab | 02 | null | TRASTUZUMAB | 101764216 |
| 20197115 | 20125391 | 1.61 | 78.2 | null | 2019-09-07 | 2019-09-20 | CETUXIMAB | 02 | Y | TRASTUZUMAB | 100733025 |
| 20197119 | 20125392 | 1.65 | 67 | Palliative (P) | 2019-10-10 | 2019-10-19 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100002395 |
| 20197122 | 20125393 | 1.65 | 65.9 | Adjuvant (A) | 2016-12-14 | 2017-04-20 | Capecitabine + Cisplatin | null | N | CAPECITABINE + CISPLATIN | 100991785 |
| 20197126 | 20125394 | 1.67 | 71.8 | 02 | 2020-01-23 | 2020-08-21 | Capecitabine + Cisplatin | N | Y | CAPECITABINE + CISPLATIN | 100703102 |
| 20197128 | 20125395 | 1.65 | 72.2 | Neo-adjuvant (N) | 2016-08-15 | 2016-08-26 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100192397 |
| 20197130 | 20125396 | 1.72 | 72.7 | Adjuvant (A) | 2016-08-28 | 2016-09-09 | CETUXIMAB | 02 | Y | TRASTUZUMAB | 101184869 |
| 20197133 | 20125397 | 1.75 | 81 | null | null | 2016-09-04 | CETUXIMAB | 02 | null | CETUXIMAB | 101776763 |
| 20197135 | 20125398 | 1.7 | 54.3 | Adjuvant (A) | 2017-08-23 | 2017-08-27 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 101600977 |
| 20197136 | 20125399 | 1.61 | 52.2 | 02 | 2016-05-27 | 2016-06-11 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN | 100895615 |
| 20197138 | 20125400 | null | null | Palliative (P) | 2016-02-16 | 2016-02-16 | CETUXIMAB | 02 | N | CETUXIMAB | 100098414 |
| 20197139 | 20125401 | 1.82 | 75 | Neo-adjuvant (N) | null | 2019-01-04 | CETUXIMAB | 02 | N | CETUXIMAB | 101045041 |
| 20197140 | 20125402 | 1.83 | 64.5 | Neo-adjuvant (N) | 2017-01-25 | 2017-02-19 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100488821 |
| 20197141 | 20125403 | 1.76 | 62.6 | Palliative (P) | 2019-04-05 | 2019-04-08 | CETUXIMAB | 02 | N | CETUXIMAB | 101667895 |
| 20197142 | 20125404 | 1.74 | 71.3 | Neo-adjuvant (N) | 2017-06-28 | 2017-07-01 | CETUXIMAB | 02 | N | CETUXIMAB | 100951212 |
| 20197143 | 20125405 | 1.66 | 65.1 | Palliative (P) | 2015-08-02 | 2016-03-09 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 100403802 |
| 20197146 | 20125406 | 1.63 | 41.6 | null | 2016-05-15 | 2016-05-29 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 100516794 |
| 20197152 | 20125407 | 1.8 | 63.7 | Curative (C) | 2017-06-27 | 2017-06-27 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101057879 |
| 20197153 | 20125408 | 1.76 | 69.2 | Neo-adjuvant (N) | 2017-02-05 | 2017-02-11 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101346124 |
| 20197154 | 20125409 | 1.8 | 75 | Adjuvant (A) | 2017-01-16 | 2017-01-30 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100651429 |
| 20197159 | 20125410 | 1.58 | 48.7 | Curative (C) | 2017-01-30 | 2017-02-19 | CETUXIMAB | 02 | Y | CETUXIMAB | 100116477 |
| 20197163 | 20125411 | 1.8 | 68.1 | Palliative (P) | 2018-08-26 | 2018-10-10 | Trastuzumab | 02 | N | TRASTUZUMAB | 101708250 |
| 20197165 | 20125412 | 1.74 | 88.1 | null | 2017-11-04 | 2017-12-06 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101788470 |
| 20197167 | 20125413 | 1.8 | 51 | null | 2017-02-13 | 2017-02-15 | Trastuzumab 21 day maintenance | N | N | TRASTUZUMAB | 101036628 |
| 20197171 | 20125414 | 1.72 | 65.1 | Palliative (P) | 2019-07-23 | 2019-07-25 | Trastuzumab | 02 | N | TRASTUZUMAB | 100380772 |
| 20197174 | 20125415 | 1.75 | 60.5 | Curative (C) | 2016-04-02 | 2017-11-05 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101239431 |
| 20197175 | 20125416 | 1.74 | 87.6 | Neo-adjuvant (N) | 2020-03-08 | 2020-03-29 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100181994 |
| 20197180 | 20125417 | 1.59 | 77.2 | null | 2019-08-07 | 2019-08-29 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101550203 |
| 20197182 | 20125418 | 1.87 | 75 | Adjuvant (A) | 2019-12-02 | 2019-12-26 | CETUXIMAB | 02 | N | CETUXIMAB | 100846591 |
| 20197183 | 20125419 | 1.74 | 64.3 | Curative (C) | 2018-09-01 | 2019-04-01 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 100663202 |
| 20197185 | 20125420 | 1.74 | 104.2 | Neo-adjuvant (N) | null | 2019-04-28 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100209088 |
| 20197197 | 20125421 | 1.84 | 87 | Palliative (P) | 2017-06-05 | 2019-12-27 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101450114 |